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Objectives: To determine if non-invasive cerebral perfusion estimation provided by a new acousto-optic technology can be used as a reliable predictor of neurological outcome.
Patients and Methods: We performed a prospective, observational cohort study of consecutive comatose patients
successfully resuscitated from out-of-hospital cardiac arrest. Patients were monitored using c-FLOW (Ornim
Medical) from critical care unit admission up to 72 h, full awakening, or death. Primary outcome was favourable
neurological outcome at hospital discharge, deﬁned as a Cerebral Performance Category score of 1 or 2.
Results: A total of 21 patients were enrolled, without any loss to follow-up. Mean perfusion index over the
monitoring period was not associated with functional outcome at hospital discharge (OR 1.03 [0.93, 1.17]).
Adjustment for initial rhythm, time to return of spontaneous circulation and Glasgow coma scale motor score did
not signiﬁcantly alter the results (OR 1.06 [0.99, 1.12]). Mean perfusion index showed a poor discriminative
value with an area under the curve of 0.60 for functional outcome (0.64 for survival). Correlation between the
probes was weak (Pearson coeﬃcient 0.35).
Conclusion: Cerebral perfusion monitoring using a c-FLOW device in survivors of cardiac arrest is feasible, but
reliability of the information provided has yet to be demonstrated. In our cohort, we were unable to identify any
association between the perfusion index and clinical outcomes at discharge. As such, clinical management of
cardiac arrest patients based on non-invasive perfusion index is not supported and should be limited to research
protocols. The trial was registered with ClinicalTrials.gov, number NCT02575196.

1. Introduction
Cerebral perfusion optimization is a crucial component of the
management of brain-injured patients. However, available noninvasive
technologies to monitor cerebral blood ﬂow (CBF) suﬀer from many
limitations preventing their regular bedside use. A recent method based
on the acousto-optic eﬀect might oﬀer a solution. Released in 2015, the
c-FLOW™ (Ornim Medical) claims to allow portable, continuous, realtime, non-invasive monitoring of brain perfusion. Born from hybridization of optical and ultrasound technologies, it uses focused

ultrasound to modulate light in the near-infrared spectrum in tissue,
allowing depth-selective continuous monitoring of capillary blood ﬂow
[1].
Cerebral perfusion can ﬂuctuate tremendously following return of
spontaneous circulation (ROSC) after cardiac arrest. CBF is reduced by
50 %–80 % in the ﬁrst hours [2] following arrest secondary to cerebral
vasoconstriction, probably mediated by endothelin release [3] and increased intracellular free calcium. Subsequent to this initial phase of
hypo-perfusion, pressure autoregulation and metabolic coupling are
impaired [4] and rebound hyperemia presumably occurs in the ensuing
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ultrasound gel and connected to the c-FLOW™ monitor. The monitor
displays a Cerebral Flow Index (CFI) for each probe, which describes
changes in cortical CBF in arbitrary units ranging from 0 to 100, with 0
representing no ﬂow. The CFI is updated every 3 s. The probes emit
near-infrared laser light (808 nm) and determine the concentration of
oxy and deoxy-haemoglobin based on distinct absorption characteristics of each. This light is tagged (i.e. its frequency distribution is
changed) by a concomitant ultrasound beam, allowing depth-speciﬁc
readings. A proprietary algorithm provides ﬂow change estimation,
relayed in the form of CFI. Of note, CFI is a strictly relative value that is
correlated with but does not directly correspond to actual CBF in mL/
100 g/min. Each patient was studied with one of the two available
monitors. Treating clinicians were blinded to CFI values. Monitoring
was left in place until death, full awakening, or for a maximum of 72 h.
CFI monitoring was temporarily interrupted to allow for imaging,
electroencephalography, or other procedures such as percutaneous
coronary intervention. Individual data was downloaded immediately
after probe removal.

hours [5], followed again by a second more protracted reduction in CBF
(the low-reﬂow phenomenon). These changes are but one aspect of the
multiple mechanisms of injury that underlie neuronal injury after
transient global ischemia and reperfusion. In the worst case scenario,
cardiac arrest patients suﬀer diﬀuse and symmetric ischemic brain injury which manifests as laminar necrosis on diﬀusion weighted imaging
[6].
Given the prominent CBF perturbations that occur after cardiac
arrest, noninvasive monitoring of cerebral perfusion is an attractive
clinical application. To date most studies in this area have focused on
regional brain tissue haemoglobin saturation monitoring [7,8], or
transcranial Doppler-derived measurements of cerebral blood ﬂow velocity measurements [9]. To our knowledge, no on has attempted to
measure brain perfusion after cardiac arrest using acousto-optic based
technology.
We therefore sought to determine, in this pilot study of resuscitated
comatose cardiac arrest patients, if CBF estimation provided by the cFLOW device is (1) feasible and reliable (2) correlated with neurological outcome, and (3) capable of identifying a clinically useful
threshold value that could dictate therapeutic intervention.

2.4. Outcome Assessment
2. Patients and Methods
The primary outcome was favourable neurological outcome at
hospital discharge. A cerebral performance category score (CPC) of 1
(mild or no neurological deﬁcit) or 2 (moderate cerebral disability) was
considered a good neurological outcome. Members of the research team
assessing CPC were unaware of monitoring results. Secondary outcomes
were survival to hospital discharge and monitoring feasibility, based on
a percentage of adequate readings over monitoring time.

2.1. Study Population
We performed a single-center, phase 2, prospective, observational,
pilot inception cohort study of consecutive adult patients successfully
resuscitated from a cardiac arrest between October 2015 and March
2016. Adult patients with sustained ROSC within 60 min of arrest that
were unresponsive and unable to follow command (i.e. comatose) were
eligible. Subjects with partially or fully dependent functional status
prior to arrest, as well as those with concomitant primary neurological
injury (traumatic brain injury, subarachnoid haemorrhage, massive
stroke or intracerebral haemorrhage) were excluded. Those with severe
co-morbidity or terminal illness making survival to three months unlikely were also excluded. The study was approved by the Icahn School
of Medicine Institutional Review Board. A waiver of the requirement for
written informed consent was secured to allow us to collect information
in the immediate post-resuscitation phase as the study posed no risk to
the patient. Consent was obtained from a legally authorized representative as soon as feasible, and from the patient if they regained
consciousness. ORNIM Medical provided two c-FLOW™ monitors for
research purposes, but were not involved in study design, data collection and analysis, or in the drafting of this manuscript.

2.5. Statistical Analysis
Continuous and normally distributed variables were summarized by
providing the mean and standard deviation and compared using independent sample Student’s t-test with equal variance. Categorical
variables were expressed as absolute and relative frequencies and
compared using the chi-square test, or Fisher’s exact test in the presence
of expected small values. Logistic regression was used to measure the
association between mean CFI and the odds of favourable functional
outcome and of survival at discharge. Univariable and multivariable
logistic regressions were employed to investigate unadjusted and adjusted odds ratios (ORs) with 95 % conﬁdence intervals. Variables expected to aﬀect the outcome and survival were analysed and initial
rhythm, time to ROSC and admission GCS motor score, the three most
powerful predictors of outcome in our cohort, were included in the
multivariable model. Invalid readings due to poor signal as well as
aberrant values were discarded before analysis. A receiver operating
characteristic (ROC) curve was plotted and the area under the curve
(AUC) calculated to evaluate the ability of CFI to discriminate between
good and poor functional outcome as well as between survivors and
non-survivors. Sensitivity analyses were conducted using median CFI,
the ﬁrst 24 h mean CFI, lowest CFI value and CFI variability. They were
also repeated using only the probe with the highest, then the probe with
the lowest, mean CFI values. We also controlled for which of the two
monitors were used. Individual simultaneous readings obtained from
each probe in any given patient were compared using Pearson correlation and paired t-test. Finally, we conducted post-hoc analyses on
dynamic measures of CFI to explore the potential association between
(1) exposure to low ﬂow in the ﬁrst 24 h using areas-under-the curve
(AUC) of CFI over time and (2) CFI trends in the ﬁrst 12 and 24 h by
computing a regression line of CFI over time, and outcome. All analyses
were performed using RStudio version 1.0.136. The trial was registered
with ClinicalTrials.gov, number NCT02575196.

2.2. Clinical Management and Data Collection
Post-resuscitation care was provided per contemporary guidelines.
All patients were admitted to a critical care unit. Haemodynamic support was exclusively pharmacologic (i.e. vasopressors) in our cohort.
Every patient was mechanically ventilated at admission and targeted
temperature management (35 °C in most cases) was applied unless a
contraindication was present.
Demographic data, medical history and clinical features at onset
were obtained by interview with family members and review of the
medical record shortly after admission. Data collected included cardiac
arrest and resuscitation characteristics including location of arrest,
suspected cause of arrest, initial rhythm, and time to ROSC. Admission
neurological status was evaluated with the Glasgow Coma Scale (GCS),
the Full Outline of UnResponsiveness (FOUR score), and pupillary light
reactivity.
2.3. c-FLOW™ Monitoring
As soon as possible after admission to the ICU, probes were applied
bifrontally using proprietary adhesive mountings and standard
2
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3. Results

Table 2
Absolute CFI values and univariate odds of favourable neurological outcome at
hospital discharge according to CFI parameters.

3.1. Admission Characteristics and Functional Outcome at Hospital
Discharge
A total of 26 patients were eligible during the study period, of which
21 were enrolled. Reasons for exclusion were time to ROSC over 60 min
(2 patients), fully dependent functional status before arrest (1 patient)
and research personnel being unavailable (2 patients). Characteristics
of included and excluded patients did not signiﬁcantly diﬀer. There was
no loss to follow-up.
Five of the 21 patients (24 %) had a good neurological outcome, and
3 of these patients were discharged to home. Amongst the 16 patients
with unfavourable outcome, 12 (75 %) were dead at discharge and four
were discharged to a facility with a CPC score of 3 (conscious but severely disabled); there was no patient in a vegetative state at discharge.
Of the 12 patients who died, the cause of death was brain death in 2
patients, re-arrest or multi-organ failure in 3, and limitation or withholding of life sustaining therapies based on a dismal neurological
prognosis in 7 patients. The limitation or withholding of life sustaining
therapy based on prognosis was made no earlier than 4 days after
ROSC. In our cohort, a shockable rhythm, a shorter time to ROSC, and a
reassuring admission neurological exam (based on the FOUR score and
GCS motor score) were associated with a favourable functional outcome
(Table 1).

CFI parameter
analysed

Good
outcome

Poor
outcome

OR

95 % CI

P value

Mean
Median
Mean in ﬁrst 24 h
Median in ﬁrst 24 h
Median – left probe
Median – right probe
Mean – highest probe
Mean – lowest probe
Lowest value
Lowest value 24 h
Variability
Mean – device 1
Mean – device 2

60.2
57.4
58.5
50.0
63.0
56.2
66.3
56.0
30.4
33.5

57.5
55.0
53.2
51.6
50.2
66.6
67.6
50.5
28.7
37.9

59.2
64.3

50.1
64.9

1.03
1.02
1.04
0.98
1.16
0.97
1.00
1.19
1.06
0.98
0.87
1.18
0.98

0.93,
0.93,
0.94,
0.80,
1.02,
0.90,
0.93,
0.99,
0.88,
0.78,
0.65,
0.99,
0.63,

0.58
0.65
0.52
0.84
0.13
0.09
0.89
0.12
0.55
0.75
0.29
0.37
0.86

1.17
1.14
1.21
1.13
1.41
1.02
1.06
1.53
1.27
1.06
1.12
1.51
1.42

similar for association with survival, whether in univariate (OR 1.02
[0.95–1.09]) or multivariate (OR 1.05 [0.95, 1.17]) analyses. Sensitivity analyses did not yield diﬀerent results. In post-hoc analyses, exposure to low ﬂow in the ﬁrst 24 h, as detected using the AUC of CFI
over time, was not signiﬁcantly diﬀerent between patients with favourable or unfavourable outcome. CFI trends in the ﬁrst 12 h and in
the ﬁrst 24 h were also not signiﬁcantly diﬀerent between patients with
favourable or unfavourable outcome.

3.2. Association Between CFI Values and Outcome
3.3. Monitoring Feasibility and Reliability

Mean CFI over the monitoring period was not associated with
functional outcome at hospital discharge (OR 1.03 [0.93, 1.17],
Table 2). Adjustment for initial rhythm, time to ROSC and GCS motor
score did not signiﬁcantly alter the results (OR 1.06 [0.99, 1.12]). Mean
CFI showed a poor discriminative value after ROC curve analysis
(Fig. 1), with an AUC of 0.60 for favourable functional outcome (CPC 1
or 2) and 0.64 for death at discharge. Analyses of multiple other CFI
parameters were also negative (Table 2). Highest CFI in the ﬁrst 24 h or
overall was 98 for everyone and could not be analysed. Results were

Monitoring was started on average 15 h after ROSC, with 62 % of
the patients started in the ﬁrst 12 h after arrest (Table 1). Inadequate
readings represented on average 16 % of all recorded values and were
secondary to leads falling oﬀ, dried ultrasound gel, or failure of the
adhesive mountings. Overall correlation between the left and right
probes (Fig. 2) was weak and potentially non-existent (Pearson coeﬃcient 0.35, P-value 0.13), with a mean diﬀerence between CFI values of

Table 1
Distribution of baseline, clinical, and monitoring characteristics according to neurological outcome.
All patients (n = 21)

Good outcome (n = 5)

Poor outcome (n = 16)

P value

Baseline characteristics
Mean age, years
Male

60 ± 17
10 (48)

58 ± 12
3 (60)

61 ± 19
7 (44)

0.63
0.63*

Medical history
Hypertension
Diabetes
Prior MI

17 (77)
11 (50)
3 (14)

5 (100)
4 (80)
0 (0)

12 (75)
7 (44)
3 (19)

0.53*
0.31*
0.55*

Cardiac arrest characteristics
Out-of-hospital
Cardiac cause of arrest
FV/VT initial rhythm
Time to ROSC, minutes

10
11
10
23

1 (20)
4 (80)
4 (80)
13 ± 3

9 (56)
7 (44)
6 (38)
26 ± 15

0.31*
0.34*
0.15*
0.007

Admission characteristics
SOFA score, mean ( ± SD)
Lactates, mean ( ± SD)
FOUR score, mean ( ± SD)
GCS motor, mean ( ± SD)
Bilateral unreactive pupils

8.6 ± 3.1
7.0 ± 3.9
4.3 ± 4.3
2.8 ± 2.1
10 (48)

7.6 ± 2.6
4.5 ± 3.2
10.6 ± 4.3
4.1 ± 2.0
1 (20)

8.9 ±
7.8 ±
2.6 ±
1.8 ±
9 (56)

0.38
0.13
0.01
0.01
0.56*

Monitoring characteristics
Delay from arrest to monitoring, hours
Monitoring duration, hours
Percentage of monitoring time with adequate signal

13 ± 11
49 ± 21
84 ± 12

13 ± 17
44 ± 21
82 ± 9

14 ± 8
50 ± 21
85 ± 15

(48)
(52)
(48)
± 14

3.4
3.6
2.3
1.5

0.88
0.69
0.57

Data are N (%), or mean ± SD.
* Fisher’s exact test.
3
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and after were signiﬁcantly diﬀerent, although not systematically recorded.
4. Discussion
Our study could not demonstrate any association between CFI
measurements and neurological outcome or survival at hospital discharge in a population of unconscious cardiac arrest survivors. To our
knowledge, this is the ﬁrst study designed to evaluate the association
between acousto-optic CBF measurements and clinically relevant outcomes. No threshold value could be identiﬁed to potentially guide
clinicians for therapeutic interventions. Although small studies had
previously demonstrated CBF variations in the aftermath of cardiac
arrest, they were also unable to associate these potentially important
physiologic changes to the outcome [9]. It is therefore possible that the
negative results in our study reﬂect a real absence of association between cerebral perfusion and outcome, as our power to detect one
standard deviation in CFI values between favourable and unfavourable
functional outcome was 90 % at a signiﬁcance level of 0.05.
However, discrepancies between values simultaneously obtained by
the probes cast serious doubts on the clinical signiﬁcance of CFI as a
monitoring tool. The within-patient mean diﬀerence between left and
right was three times larger than the mean diﬀerence between two
groups with diﬀerent outcomes (Table 2). Even though the c-FLOW
does not purport to provide absolute CBF values, the lack of correlation
between probes both at group and at individual levels provides confusing data. In 2012, a pre-clinical study compared changes in CFI to
changes in CBF as measured with 133Xenon single photon emission
computer tomography in healthy patients after intravenous bolus of
acetazolamide [10]. Although CBF and CFI both went up at ﬁrst, they
harboured an inverse relationship after 45 min. Moreover, the

Fig. 1. Receiver operating characteristic (ROC) curve analysis of favourable
neurological outcome at discharge by mean CFI value during the monitoring
period. Area under the curve (AUC): 0.60.

13 (P-value 0.003). At the patient level, CFI values obtained over time
by the two probes had a negative correlation in 3 patients, a low or
negligible correlation in 12 patients, and high correlation in only 3.
Another technical problem arose after realization that every time the
probes were removed for a few seconds to renew the ultrasound gel
between the adhesive mounting and the probe, values obtained before

Fig. 2. Relationship between left and right probes median CFI values (overall median left CFI = 51 and median right CFI = 61) Pearson coeﬃcient 0.35, P-value
0.13. Two points missing (data on 19 correlations out of 21 patients) as one of the probes was deemed too unreliable and has been rejected in analysis in 2 patients.
4
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following: (1) conceptualization, methodology, software, validation,
formal analysis, investigation or data curation and (2) original draft
preparation, review or editing.

technology did not compare well to transcranial Doppler in a cardiac
arrest patient population with regard to its ability to track changes in
blood ﬂow velocity [10]. Even more worrisome, a recent study found
signiﬁcantly higher CFI values in brain dead patients than in healthy
patients, as well as marked diﬀerence between hemisphere, conﬁrming
our ﬁndings [11].
The strengths of our study include the following. Our cohort of
patients represented a homogeneous type of brain injury, namely post
anoxic encephalopathy. Exclusion criteria and brain imaging conﬁrmed
the absence of underlying or concomitant asymmetric or structural
brain damage. Clinical management was in line with the most recent
guidelines. Monitoring was started in a timely fashion, in less than 12-h
post-ROSC in most patients. Sensor positioning and maintenance were
made exclusively by research team members who were trained by
ORNIM personnel. Two diﬀerent monitors were used with similar
conclusions, eﬀectively ruling out software or hardware malfunction.
Clinicians were blinded to CFI values and could not have altered their
management based on the study results. An expert team made prognostication according to contemporary guidelines. Limitation or withholding of life sustaining therapies were never applied before 72 h. The
CPC was calculated by research team members who were unaware of
the patient’s CFI values. Survival at discharge with favourable neurological outcome deﬁned as a CPC 1 or 2 is consistent with current
Utstein guidelines.
Our study also suﬀers limitations. The a priori link between CBF and
outcome in the cardiac arrest population has never been proven in
humans, which limits our ability to draw solid conclusions on CFI validation. Moreover, we did not have a gold standard CBF monitoring to
provide adequate comparison. However, the study objective was not to
assess the device accuracy. The observational design and small number
of patients also limit our ability to control for potential confounding,
although both treating team and outcome evaluators were blinded.
Finally, ORNIM has recently released a modiﬁed version of their algorithm to calculate CFI, which was not evaluated.
In conclusion, cerebral perfusion monitoring using a c-FLOW device
in survivors of cardiac arrest is feasible, but reliability of the information provided has yet to be demonstrated. In our cohort, we were unable to identify any association between the perfusion index and clinical outcomes at discharge. As such, clinical management of cardiac
arrest patients based on non-invasive perfusion index is not supported
and should be limited to research protocols.
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